Hedge Funds Have Never Been This Bullish On Bristol Myers Squibb Company (BMY)
Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by nearly 9 percentage points since the end of the third quarter of 2018 as investors worried......(read more)
Posts Tagged ‘NYSE:BMY’
30 Most Popular Stocks Among Hedge Funds in Q1 of 2019
“By the end of the First Quarter, equity markets had mostly bounced back from Q4 2018’s sharp decline. The dovish shift in Fed policy – which......(read more)
Activist Keith Meister Says This Year’s Market Rally and Last December’s Sell-Off Made Us Break Even
In a yesterdays’ CNBC “Squawk Box” program, Corvex Management’s Keith Meister was a guest and he shared his views on the current and the future......(read more)
Hedge Fund and Insider Trading News: Starboard Value LP, Elliott Management, JMP Group LLC (JMP), TJX Companies Inc (TJX), and More
Starboard No Longer Urging Investors to Vote Against Bristol-Celgene deal (Reuters) BOSTON (Reuters) – Activist hedge fund Starboard Value LP said......(read more)
Is Bristol Myers Squibb Company (BMY) A Good Stock To Buy?
The government requires hedge funds and wealthy investors that crossed the $100 million equity holdings threshold are required to file a report that shows......(read more)
Is Bristol Myers Squibb Co. (BMY) A Good Stock To Buy According To Hedge Funds?
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors......(read more)
20 Dividend Stocks That Billionaires Are Piling On
Numerous billionaire money managers, including the likes of Warren Buffett and Ken Fisher, absolutely love dividend stocks (check out a list of Ken Fisher......(read more)
Five Dividend Stocks to Follow Hedge Funds Into
Dividend yield is a very important metric that should be taken into account when picking a stock. Stocks that pay dividends usually outperform their non......(read more)
Market Movers Today: Corcept Therapeutics Incorporated (CORT), Eyegate Pharmaceuticals Inc (EYEG), Arconic Inc (ARNC), and More
Corcept Therapeutics Incorporated (NASDAQ:CORT) (MarketWatch) Shares of Corcept Therapeutics Inc. CORT, -24.10% plunged 21% in premarket trade Monday,......(read more)
5 Stocks Insiders and Hedge Funds Are Crazy About
2017 has come to a close and it’s been a wildly successful year for the stock market, as the S&P 500 jumped by 19% excluding dividends, the......(read more)
10 Biggest Antidepressant Drug Companies In 2017
The 10 biggest antidepressant drug companies in 2017 are committed to providing the safest and most cost-effective solution for consumers suffering from......(read more)
Opus Point Partners’ AUM, History and Investments
Opus Point Partners was founded by Michael S. Weiss and Dr. Lindsay A. Rosenwald in 2009. Prior to launching Opus Point Partners, Mr. Weiss and Dr. Rosenwald......(read more)
With Stock Returns Of Over 205% in the Last Year, This Fund Is Proof That Hedge Funds Aren’t Going Anywhere
If someone is looking for convincing arguments about the wildly publicized doom of the hedge fund business, they don’t need to look far beyond the 2017......(read more)
Here’s Why Wells Fargo, eBay, CytomX Therapeutics, Dominion Diamond, and More Are Trending
The markets are relatively quiet today as there are no major economic releases. The Dow Jones index is down 10 points, while the S&P 500 is 0.23%......(read more)
Billionaire Barry Rosenstein’s Top Q4 Moves: Alphabet (GOOG), Bristol-Myers (BMY), More
Founded in 2001, JANA Partners is led by billionaire Barry Rosenstein, along with co-portfolio managers David DiDomenico and Scott Ostfeld. It is a value......(read more)
Director at Giant Drugmaker Buys New Stake Amid Takeover Speculations and Activist Pressure, Plus Other Insider Trading
Insider trading can be either legal or illegal. The illegal kind of insider trading occurs when corporate insiders or other individuals buy or sell securities......(read more)
Billionaire Julian Robertson Bets Big on Technology Sector With These Stocks
Julian Robertson is an iconic hedge fund manager who started Tiger Management in 1980. Not only is he famous for his own hedge fund, but he also seeded......(read more)
Bristol-Myers Squibb Co (BMY) To Sell Senior Notes As Formidable Activist Investor Shows Interest
Bristol-Myers Squibb Co (NYSE:BMY) will sell senior notes that are unsecured worth $1.5 billion. Half of that amount is due in two years at a rate of......(read more)
Bristol-Myers Squibb Co (BMY), Merck & Co., Inc. (MRK), And Other Pharmaceutical Firms All Targeting I-O Segment
Reports indicate that the market for immuno-oncology drugs could grow to $25 billion in the next ten years. Pharmaceutical firms such as Bristol-Myers......(read more)
Here Are The Major Moves Made By Bridgewater Associates Going Into 2017
2016 was again a dismal year for the hedge fund industry, with a lot of hedge funds failing to beat the benchmark and some trailing it by a huge margin......(read more)
Bristol-Myers Squibb Co (BMY) To Share In Sales Of Merck & Co., Inc. (MRK) Keytruda Following Litigation Settlement
Merck & Co., Inc. (NYSE:MRK) has agreed to share a portion of Keytruda sales with Bristol-Myers Squibb Co (NYSE:BMY) and Ono Pharmaceutical Co., Ltd......(read more)
Bristol-Myers Squibb Co (BMY) Agrees To Extend Research With Five Prime Therapeutics Inc (FPRX)
Bristol-Myers Squibb Co (NYSE:BMY) has opted to extend the research term of its discovery collaboration agreement with Five Prime Therapeutics Inc (NASDAQ......(read more)
Gilead Sciences, Inc. (GILD) Is A Hail Mary: 3 Better Stocks To Consider
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences......(read more)
Bristol-Myers Squibb Co (BMY) And Pfizer Inc. (PFE) Agree To $50 Million Loan To Portola Pharmaceuticals Inc (PTLA)
There is a need for additional funding towards the development and clinical studies of AndexXa, a new compound that is a prospective antidote for Factor......(read more)
5 Healthcare Stocks Billionaires Are Buying
Billionaire investors are successful for a reason. They do not funnel their money in ordinary places. They spend enormous amounts of resources on the......(read more)
D E Shaw Makes Massive Investments in Apple, Disney, More
David E. Shaw is an American computer scientist and investor who founded D.E. Shaw & Co., L.P. in 1988. The hedge fund manages a 13F portfolio of......(read more)
$50 Billion Quant Fund Is Making New Bets On These Stocks
Renaissance Technologies is probably the best quant hedge fund in the market. Their Medallion Fund literally prints $1 billion to $3 billion a year and......(read more)
Is Bristol Myers Squibb Co. (BMY) Worthy Of Your Portfolio?
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Valeant and SunEdison, have not done well during the last......(read more)
A Look At Billionaire Julian Robertson’s Top Dividend Picks
Hedge fund legend Julian Robertson closed his hedge fund Tiger Management to outside investors way back in 2000 and has been using it as a vehicle to......(read more)
Billionaire Julian Robertson Takes Out Huge SPY Hedge, Grows Bearish on Transportation Stocks
Tiger Management is a New York-based hedge fund founded in 1980 by legendary investor and billionaire Julian Robertson. The original ‘Tiger Fund......(read more)
Bristol Myers Squibb Co. (BMY), Alkermes Plc (ALKS) & More: How Opus Point’s Bet on Healthcare Sector Paid Off?
Opus Point Partners Management is a New York-based fund led by Michael S. Weiss and Lindsay A. Rosenwald. Opus Point’s equity portfolio is worth $178......(read more)
Bristol-Myers Squibb Company (BMY), Infinity Pharmaceuticals, Inc. (INFI) Team Up On Opdivo Combination Therapy
Bristol-Myers Squibb Co (NYSE:BMY) and Infinity Pharmaceuticals Inc. (NASDAQ:INFI) have recently entered into an agreement to commence a collaborative......(read more)
Scout Daily Update: Core Durable Goods Down 21 Straight Months
STOCK NEWS Twitter Inc (NYSE:TWTR): reported Q3 EPS of $0.13 which beat estimates by 4 cents. Revenue of $616 million was up 8.2% which beat estimates......(read more)
Here’s Why Bristol-Myers Squibb Co (BMY), Telefonica Brasil SA (ADR) (VIV) and Three Other Stocks Plunged on Monday
Markets are trading on an optimistic note as all the major indices are in green zone. The major push for the markets comes from Hillary Clinton being......(read more)
VeriFone (PAY), Gilead (GILD) Among 5 Stocks That Hit 52-Week Lows Last Week
Although the S&P 500 and Dow Jones are near record highs, shares of five major companies crumbled to 52-week lows last week. In this article we’......(read more)
Why Do Hedge Funds Like Five Prime Therapeutics?
Five Prime Therapeutics Inc (NASDAQ:FPRX) is a $1.25 billion biotech company that focuses on the discovery and development of protein therapeutics that......(read more)
Why Dean Foods, Bristol-Myers, and Three Other Stocks Are on the Move Today
US stocks are trading slightly lower on Monday afternoon, as the major indexes retrieved from all-time highs reached on Friday, and a spike in energy......(read more)
10 NYSE Stocks Hitting 52-Week Highs Tuesday
Bull sentiment dominated the markets during the first two trading sessions of the week, thanks to growing optimism about economic growth in the U.S after......(read more)
Cheniere Energy Inc. (LNG) and Vince Holding Corp (VNCE) See Their CEOs Buy Shares; Three Other Companies Register Insider Selling
While there is no way to either deny or confirm the following statement, there is good reason to believe that hedge fund vehicles usually do not pay too......(read more)
The Highest-Earning Hedge Fund Manager in 2015 Reveals His Top Stock Picks for Q2
Chicago billionaire Ken Griffin, the Founder and Chief Executive Officer of Citadel Advisors, was the highest-paid hedge fund manager in 2015, earning......(read more)
Here’s Why Investors Are Watching These Five Stocks Today
It’s the middle of earnings season and many investors are hungrily dissecting earnings reports and management commentary to get a better view on......(read more)
Stocks Financial Advisors Are Interested In: Costco, Facebook & More
Last week was marked by the S&P 500 entering into its eighth year of bull run amid an increase in oil prices and hopes of more stimulus from central......(read more)
Is Bristol Myers Squibb Co. (BMY) Going to Burn These Hedge Funds?
Hedge fund managers like David Einhorn, Dan Loeb, and Carl Icahn became billionaires by reaping large profits for their investors, which is why piggybacking......(read more)
Hedge Funds Are Buying These 10 Large-Caps, Part 2
Large-cap stocks are generally less immune to sharp moves based on rumors than their mid and small-cap counterparts. While this characteristic ensures......(read more)
Here is What Hedge Funds Think About Bristol Myers Squibb Co. (BMY)
You probably know from experience that there is not as much information on small-cap companies as there is on large companies. Of course, this makes it......(read more)
Sector Concerns Not Scaring Clifford Fox Away From These 5 Healthcare Stocks
Clifford Fox’s Columbus Circle Investors is a multi-billion dollar investment management firm that has been primarily successful in picking small......(read more)
Why Are These Stocks Surging Today?
It’s Thursday and shareholders of BofI Holding, Inc. (NASDAQ:BOFI), and Five Prime Therapeutics Inc (NASDAQ:FPRX) are certainly happy as the value......(read more)
Medtronic PLC (MDT), Actavis plc (ACT): Zweig-DiMenna Partners Top Picks from Healthcare Sector
Zweig-DiMenna Partners is a US-based hedge fund managed by Joseph A. DiMenna, who co-founded the fund with Martin Zweig back in 1984. Zweig-Dimenna......(read more)
Healthcare Hedge Fund Orbimed’s Top Picks and New Move
According to a Schedule 13D form filed yesterday with the Securities and Exchange Commission, Samuel Islay‘s Orbimed Advisors has slashed its stake......(read more)
Bristol-Myers Squibb Co (BMY) Sues Merck & Co., Inc. (MRK) Over Cancer Drug, Position Strong
Bristol-Myers Squibb Co (NYSE:BMY) along with Ono Pharmaceutical launched a lawsuit against Merck & Co., Inc. (NYSE:MRK) last Thursday, claiming that......(read more)
